Literature DB >> 19521349

Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats.

Angelo A Izzo1, Fabiana Piscitelli, Raffaele Capasso, Pietro Marini, Luigia Cristino, Stefania Petrosino, Vincenzo Di Marzo.   

Abstract

N-oleoylethanolamine (OEA) and N-palmitoylethanolamine (PEA) are endogenous lipids that activate peroxisome proliferator-activated receptor-alpha with high and intermediate potency, and exert anorectic and anti-inflammatory actions in rats, respectively. We investigated OEA and PEA tissue level regulation by the nutritional status in lean and obese rats. OEA and PEA levels in the brainstem, duodenum, liver, pancreas, and visceral (VAT) or subcutaneous (SAT) adipose tissues of 7-week-old wild-type (WT) and Zucker rats, fed ad libitum or following overnight food deprivation, with and without refeeding, were measured by liquid chromatography-mass spectrometry. In WT rats, duodenal OEA, but not PEA, levels were reduced by food deprivation and restored by refeeding, whereas the opposite was observed for OEA in the pancreas, and for both mediators in the liver and SAT. In ad lib fed Zucker rats, PEA and OEA levels were up to tenfold higher in the duodenum, slightly higher in the brainstem, and lower in the other tissues. Fasting/refeeding-induced changes in OEA levels were maintained in the duodenum, liver, and SAT, and lost in the pancreas, whereas fasting upregulated this compound also in the VAT. The observed changes in OEA levels in WT rats are relevant to the actions of this mediator on satiety, hepatic and adipocyte metabolism, and insulin release. OEA dysregulation in Zucker rats might counteract hyperphagia in the duodenum, but contribute to hyperinsulinemia in the pancreas, and to fat accumulation in adipose tissues and liver. Changes in PEA levels might be relevant to the inflammatory state of Zucker rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19521349     DOI: 10.1038/oby.2009.186

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  24 in total

1.  Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.

Authors:  Mónica Alonso; Antonia Serrano; Margarita Vida; Ana Crespillo; Laura Hernandez-Folgado; Nadine Jagerovic; Pilar Goya; Carmen Reyes-Cabello; Vidal Perez-Valero; Juan Decara; Manuel Macías-González; Francisco Javier Bermúdez-Silva; Juan Suárez; Fernando Rodríguez de Fonseca; Francisco Javier Pavón
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure.

Authors:  Reiner Jumpertz; Ana Guijarro; Richard E Pratley; Daniele Piomelli; Jonathan Krakoff
Journal:  J Clin Endocrinol Metab       Date:  2010-12-22       Impact factor: 5.958

3.  Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake.

Authors:  Gustavo Provensi; Roberto Coccurello; Hayato Umehara; Leonardo Munari; Giacomo Giacovazzo; Nicoletta Galeotti; Daniele Nosi; Silvana Gaetani; Adele Romano; Anna Moles; Patrizio Blandina; Maria Beatrice Passani
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-21       Impact factor: 11.205

4.  The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119.

Authors:  Virginia M Stone; Shalinee Dhayal; David M Smith; Carol Lenaghan; Katy J Brocklehurst; Noel G Morgan
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

5.  Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.

Authors:  Raffaele Capasso; Pierangelo Orlando; Ester Pagano; Teresa Aveta; Lorena Buono; Francesca Borrelli; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

6.  Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.

Authors:  Giovanni Annuzzi; Fabiana Piscitelli; Lucrezia Di Marino; Lidia Patti; Rosalba Giacco; Giuseppina Costabile; Lutgarda Bozzetto; Gabriele Riccardi; Roberta Verde; Stefania Petrosino; Angela A Rivellese; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2010-04-28       Impact factor: 3.876

7.  Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels.

Authors:  Francesca Rossi; Silverio Perrotta; Giulia Bellini; Livio Luongo; Chiara Tortora; Dario Siniscalco; Matteo Francese; Marco Torella; Bruno Nobili; Vincenzo Di Marzo; Sabatino Maione
Journal:  Haematologica       Date:  2014-09-12       Impact factor: 9.941

8.  Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.

Authors:  Francesca Borrelli; Barbara Romano; Stefania Petrosino; Ester Pagano; Raffaele Capasso; Diana Coppola; Giovanni Battista; Pierangelo Orlando; Vincenzo Di Marzo; Angelo A Izzo
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

9.  N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans.

Authors:  Mark Lucanic; Jason M Held; Maithili C Vantipalli; Ida M Klang; Jill B Graham; Bradford W Gibson; Gordon J Lithgow; Matthew S Gill
Journal:  Nature       Date:  2011-05-12       Impact factor: 49.962

10.  Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice.

Authors:  Fabiana Piscitelli; Gianfranca Carta; Tiziana Bisogno; Elisabetta Murru; Lina Cordeddu; Kjetil Berge; Sally Tandy; Jeffrey S Cohn; Mikko Griinari; Sebastiano Banni; Vincenzo Di Marzo
Journal:  Nutr Metab (Lond)       Date:  2011-07-13       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.